Health Economics and Outcomes Research (HEOR) Services Market Report 2026

The health economics and outcomes research (heor) services market size has grown rapidly in recent years. It will grow from $1.76 billion in 2025 to $1.97 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing healthcare cost containment pressures, rising demand for payer-focused evidence, growth in pharmaceutical clinical research, expanding use of epidemiological data, increased reliance on outsourced research services.

The health economics and outcomes research (heor) services market size is expected to see rapid growth in the next few years. It will grow to $3.12 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing adoption of ai-driven health economic models, rising demand for personalized medicine assessments, expansion of real-world data availability, growing focus on outcomes-based reimbursement, increasing regulatory scrutiny on pricing strategies. Major trends in the forecast period include increasing use of real-world evidence analytics, rising demand for value-based healthcare assessments, growing integration of advanced economic modeling, expansion of market access consulting services, enhanced focus on regulatory-compliant outcomes research.

The surge in the number of clinical trials is expected to drive the growth of the health economics and outcomes research (HEOR) services market going forward. Clinical trials are research studies involving human participants to assess the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. HEOR services are applied in clinical trials to evaluate the economic impact, cost-effectiveness, and real-world outcomes of medical interventions, providing critical insights for decision-making and reimbursement strategies. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, the growing number of clinical trials is fueling the expansion of the HEOR services market.

Major companies in the HEOR services market are focusing on developing services for digital therapeutics providers. Companies are exploring the application of HEOR services across broader sectors, such as digital therapeutics, to support vendors with improved market analysis. For instance, in November 2023, Curavit, a US-based research organization, launched HEOR services for digital therapeutic trials. These services focus on assessing the health economics value of digital therapeutics at both individual patient and population care levels. To quantify the financial impact of the digital therapeutic, HEOR is incorporated into clinical trials and analyzed at study close-out.

In January 2023, SCIRIS, a UK-based company specializing in healthcare communications and compliance solutions, acquired Source Health Economics for an undisclosed amount. Through this acquisition, SCIRIS enhanced its ability to provide comprehensive HEOR services to global clients, supporting them throughout all stages of brand development. Source Health Economics, based in the UK, is a consulting company engaged in health technology assessment, statistics, health economics, and medical writing.

Major companies operating in the health economics and outcomes research (heor) services market are McKesson Corporation, Optum Inc., Cardinal Health, IQVIA Inc., ICON PLC, PPD Inc., Syneos Health, Medlior Health Outcomes Research Ltd., Axtria Inc., Parexel International, RTI Health Solutions, Wellth Inc., Westat, SidekickHealth, Analysis Group, Carelon Research, Precision Health Economics, Avalon Health Economics LLC, Lumanity Inc., Pharmerit BV, Epistemix Inc., Bohn Epidemiology LLC.

North America was the largest region in the health economics and outcomes research (HEOR) services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the health economics and outcomes research (heor) services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the health economics and outcomes research (heor) services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are indirectly impacting the HEOR services market by increasing costs of imported IT infrastructure, analytical software platforms, and data processing hardware used in large-scale economic modeling. North America and Europe are most affected due to reliance on cross-border data infrastructure and specialized analytics tools. Asia-Pacific experiences moderate cost increases tied to outsourced analytics services. However, tariffs are driving greater adoption of cloud-based analytics, regional data centers, and in-house modeling capabilities, supporting long-term service scalability.

The health economics and outcomes research (heor) services market research report is one of a series of new reports that provides health economics and outcomes research (heor) services market statistics, including health economics and outcomes research (heor) services industry global market size, regional shares, competitors with a health economics and outcomes research (heor) services market share, detailed health economics and outcomes research (heor) services market segments, market trends and opportunities, and any further data you may need to thrive in the health economics and outcomes research (heor) services industry. This health economics and outcomes research (heor) services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Health economics and outcomes research (HEOR) services represent a specialized area within healthcare that applies economic and epidemiological approaches to evaluate the clinical and financial outcomes of healthcare interventions. These services assess the cost-effectiveness, safety, and real-world impact of medical treatments, interventions, and healthcare policies.

The primary types of HEOR services include real-world evidence, payer evidence, pricing and reimbursement, epidemiology studies, market access, and other related services. Real-world evidence (RWE) involves data gathered from real-world settings, such as electronic health records, claims databases, and patient registries, to provide insights into treatment effectiveness, safety, and patient outcomes. HEOR services can be delivered either in-house or outsourced by providers such as consultancies and contract research organizations (CROs) to end-users, including healthcare providers, payers, biotechnology and pharmaceutical companies, government agencies, and others.

The health economics and outcomes research (HEOR) services market includes revenues earned by entities by providing economic modeling, health outcomes assessment, and comparative effectiveness research services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.